Seattle biotech startup backed by Gates Foundation launches trial for snail fever vaccine

The first patient is dosed in a phase 1 trial for the SchistoShield vaccine against schistosomiasis. ( Kaiser Permanente Washington Health Research Institute Photo) The first patient has…